These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37596304)

  • 21. Combined Use of CytoSorb and ECMO in Patients with Severe Pneumogenic Sepsis.
    Akil A; Ziegeler S; Reichelt J; Rehers S; Abdalla O; Semik M; Fischer S
    Thorac Cardiovasc Surg; 2021 Apr; 69(3):246-251. PubMed ID: 32252114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
    Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb
    Paul R; Sathe P; Kumar S; Prasad S; Aleem M; Sakhalvalkar P
    World J Crit Care Med; 2021 Jan; 10(1):22-34. PubMed ID: 33505870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis.
    Scharf C; Liebchen U; Paal M; Irlbeck M; Zoller M; Schroeder I
    Crit Care; 2021 Jan; 25(1):41. PubMed ID: 33509234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
    Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
    In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sivelestat sodium for treatment of patients with COVID-19-associated acute respiratory distress syndrome in intensive care unit: a single-center retrospective cohort study].
    Luo M; Hu H; Sun Y; Zhao X; Zeng Z; Liu Y; Wu G
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1259-1267. PubMed ID: 37712261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study.
    Hawchar F; László I; Öveges N; Trásy D; Ondrik Z; Molnar Z
    J Crit Care; 2019 Feb; 49():172-178. PubMed ID: 30448517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum level of human epididymal protein 4 (HE4) predicts poor prognosis in the critically ill with sepsis: A prospective observational cohort study.
    Lai X; Kang M; Chen Y; Xu F; Wang K; Cao J
    Clin Biochem; 2022; 109-110():79-85. PubMed ID: 35932794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.
    Supady A; Weber E; Rieder M; Lother A; Niklaus T; Zahn T; Frech F; Müller S; Kuhl M; Benk C; Maier S; Trummer G; Flügler A; Krüger K; Sekandarzad A; Stachon P; Zotzmann V; Bode C; Biever PM; Staudacher D; Wengenmayer T; Graf E; Duerschmied D
    Lancet Respir Med; 2021 Jul; 9(7):755-762. PubMed ID: 34000236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemoperfusion with Cytosorb in pediatric patients with septic shock: A retrospective observational study.
    Bottari G; Guzzo I; Marano M; Stoppa F; Ravà L; Di Nardo M; Cecchetti C
    Int J Artif Organs; 2020 Sep; 43(9):587-593. PubMed ID: 32003289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series.
    Mehta Y; Mehta C; Nanda S; Kochar G; George JV; Singh MK
    J Med Case Rep; 2021 Sep; 15(1):476. PubMed ID: 34535189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients.
    Pieri M; Bonizzoni MA; Belletti A; Calabrò MG; Fominskiy E; Nardelli P; Ortalda A; Scandroglio AM
    Blood Purif; 2023; 52(9-10):759-767. PubMed ID: 37669640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients.
    Peng JY; Li L; Zhao X; Ding F; Hou X; Peng Z
    Blood Purif; 2022; 51(5):410-416. PubMed ID: 34407530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous hemadsorption with cytokine adsorber for severe COVID-19: A case series of 15 patients.
    Paisey C; Patvardhan C; Mackay M; Vuylsteke A; Bhagra SK
    Int J Artif Organs; 2021 Oct; 44(10):664-674. PubMed ID: 34128416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial.
    Kanjo A; Molnar Z; Zádori N; Gede N; Erőss B; Szakó L; Kiss T; Márton Z; Malbrain MLNG; Szuldrzynski K; Szrama J; Kusza K; Kogelmann K; Hegyi P
    BMJ Open; 2021 Aug; 11(8):e050464. PubMed ID: 34446497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cytokine levels predict mortality in patients with acute renal failure.
    Simmons EM; Himmelfarb J; Sezer MT; Chertow GM; Mehta RL; Paganini EP; Soroko S; Freedman S; Becker K; Spratt D; Shyr Y; Ikizler TA;
    Kidney Int; 2004 Apr; 65(4):1357-65. PubMed ID: 15086475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study.
    Stockmann H; Thelen P; Stroben F; Pigorsch M; Keller T; Krannich A; Spies C; Treskatsch S; Ocken M; Kunz JV; Krüger A; Khadzhynov D; Kron S; Budde K; Eckardt KU; Enghard P; Lehner LJ
    Crit Care Med; 2022 Jun; 50(6):964-976. PubMed ID: 35135967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
    Takahashi W; Nakada TA; Yazaki M; Oda S
    Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.
    Friesecke S; Träger K; Schittek GA; Molnar Z; Bach F; Kogelmann K; Bogdanski R; Weyland A; Nierhaus A; Nestler F; Olboeter D; Tomescu D; Jacob D; Haake H; Grigoryev E; Nitsch M; Baumann A; Quintel M; Schott M; Kielstein JT; Meier-Hellmann A; Born F; Schumacher U; Singer M; Kellum J; Brunkhorst FM
    Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):699-707. PubMed ID: 28871441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the cytokine adsorber CytoSorb
    Scharf C; Weinelt F; Schroeder I; Paal M; Weigand M; Zoller M; Irlbeck M; Kloft C; Briegel J; Liebchen U
    Ann Intensive Care; 2022 May; 12(1):44. PubMed ID: 35599248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.